Interestingly, we previously revealed the decreased BACH2 levels in patients with T-ALL compared to those with B-ALL at newly diagnosis (ND), in line with the poorer outcome of T-ALL than B-ALL [10]. The gene discussed is BACH2; the disease is acute lymphoblastic leukemia.